A Phase IV, Multi-Center, Double-Blind, Double-Dummy, Randomized, Parallel-Group Study to Compare the Tolerability of Quetiapine Fumarate Immediate Release (Seroquel IR) With Quetiapine Fumarate Extended Release (Seroquel XR) During Initial Dose Escalation in Patients With Bipolar Depression.
Phase of Trial: Phase IV
Latest Information Update: 10 May 2011
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 27 Aug 2009 Actual end date (1 Aug 2009) added as reported by ClinicalTrials.gov.
- 27 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Aug 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.